Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale
8 months ago
Financing
Bioregnum
Septerna outlines $157M IPO after entering the clinic with GPCR pipeline
8 months ago
Financing
Former Karuna crew quickly assembles $225M for next neuro bet at Seaport
8 months ago
Financing
Secretive Treeline Biosciences discloses $421M financing in filing
8 months ago
Financing
RNA gene therapy startup Shape hunts for new CEO as Series C awaits
8 months ago
People
Cell/Gene Tx
Hospitals gush about new AI note-taking tools. It may leave the human medical scribes who originated the roles behind
8 months ago
AI
Health Tech
Life sciences investor KdT Ventures raises $100M fund to back new startups
8 months ago
Financing
Seeking to treat obesity drug side effect, Neurogastrx releases data on drug for GLP-1-associated nausea, vomiting
8 months ago
R&D
Tolerance Bio emerges from stealth with $17.2M to advance therapies developed from the thymus
8 months ago
Financing
Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock
8 months ago
Financing
R&D
VC firm targets $35M second fund to back startups led by scientists
9 months ago
Financing
Biotech startups Upstream and CAMP4 price Friday IPOs
9 months ago
Financing
Eli Lilly inks another obesity pact, doubling down on small Swiss partner
9 months ago
Deals
Suki nabs $70M Series D to arm doctors with AI tools
9 months ago
AI
Health Tech
Purespring nabs $105M to take gene therapy into the clinic as IgAN field matures
9 months ago
Financing
Cell/Gene Tx
John Maraganore's RNAi biotech City Therapeutics debuts with $135M Series A
9 months ago
Financing
Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval
9 months ago
Financing
Exclusive: Lilly backs a16z-funded Arda Therapeutics' $43M Series A to take ADCs into fibrosis
9 months ago
Financing
Astellas places new bet on gene therapy in $50M upfront deal with UK startup
9 months ago
Deals
Cell/Gene Tx
Merck partners with small UK biotech to drug fibroblasts for fibrosis, I&I diseases
9 months ago
Deals
Exclusive: Tiny startup with big vision to extend healthspan by 20 years says it discovered an ‘Atlas of Rejuvenation’
9 months ago
Financing
Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech
9 months ago
Financing
Upstream and CAMP4 target $182M, $67M IPOs
9 months ago
Financing
Biotech's third quarter was relatively bright — with a few caveats
9 months ago
Financing
Deals
First page
Previous page
9
10
11
12
13
14
15
Next page
Last page